Inventor · disambiguated record
Morten Schlein
Also filed as: SCHLEIN MORTEN
9 granted patents·16 pending applications·96 citations·filing 2004–2024
88Inventor score
Files withNOVO NORDISK AS18KJELDSEN THOMAS BØRGLUM1KNUDSEN LISELOTTE BJERRE1LUDVIGSEN SVEND1OLSEN HELLE BIRK1
Top patents by PatentIndex Score
25 records- 0190US9481721B2Insulin formulationsNOVO NORDISK AS·Filed 2013·Granted Nov 1, 2016·13 cites·25 claims
- 0290US8158583B2Soluble pharmaceutical compositions for parenteral administration comprising a GLP-1 peptide and an insulin peptide of short time action for treatment of diabetes and bulimiaKNUDSEN LISELOTTE BJERRE·Filed 2009·Granted Apr 17, 2012·18 cites·36 claims
- 0389US8883449B2Single-chain insulinKJELDSEN THOMAS BØRGLUM·Filed 2008·Granted Nov 11, 2014·21 cites·18 claims
- 0489US8324157B2Preparation comprising insulin, nicotinamide and an amino acidOLSEN HELLE BIRK·Filed 2011·Granted Dec 4, 2012·15 cites·43 claims
- 0586US8748376B2Stable formulations of peptidesLUDVIGSEN SVEND·Filed 2009·Granted Jun 10, 2014·21 cites·14 claims
- 0683US8404645B2Stable formulations of amylin and its analoguesSCHLEIN MORTEN·Filed 2008·Granted Mar 26, 2013·6 cites·8 claims
- 0783US2024424064A1Insulin containing pharmaceutical compositionsNOVO NORDISK AS·Filed 2024·Application pending·0 cites
- 0873US10265385B2Insulin containing pharmaceutical compositionsNOVO NORDISK AS·Filed 2018·Granted Apr 23, 2019·1 cites·20 claims
- 0973US2022202909A1Insulin containing pharmaceutical compositionsNOVO NORDISK AS·Filed 2022·Application pending·0 cites
- 1066US2020384088A1Insulin containing pharmaceutical compositionsNOVO NORDISK AS·Filed 2020·Application pending·0 cites
- 1164US10596231B2Insulin containing pharmaceutical compositionsNOVO NORDISK AS·Filed 2019·Granted Mar 24, 2020·0 cites·12 claims
- 1261US2006247167A1Stable formulations of peptidesNOVO NORDISK AS·Filed 2006·Application pending·0 cites
- 1360US2007129284A1Single-chain insulinNOVO NORDISK AS·Filed 2006·Application pending·0 cites
- 1460US2010222251A1Mixture comprising an amylin peptide and a protracted insulinNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 1559US8937042B2Pharmaceutical compositions comprising GLP-1 peptides or extendin-4 and a basal insulin peptidePLUM ANNE·Filed 2008·Granted Jan 20, 2015·1 cites·3 claims
- 1659US2006287221A1Soluble pharmaceutical compositions for parenteral administration comprising a GLP-1 peptide and an insulin peptide of short time action for treatment of diabetes and bulimiaNOVO NORDISK AS·Filed 2006·Application pending·0 cites
- 1759US2014206610A1Preparation Comprising Insulin, Nicotinamide and an Amino AcidNOVO NORDISK AS·Filed 2014·Application pending·0 cites
- 1857US2018169190A1Insulin containing pharmaceutical compositionsNOVO NORDISK AS·Filed 2017·Application pending·0 cites
- 1956US2013281364A1Preparation Comprising Insulin, Nicotinamide and an Amino AcidNOVO NORDISK AS·Filed 2012·Application pending·0 cites
- 2051US2010190715A1Stable Formulations of PeptidesNOVO NORDISK AS·Filed 2010·Application pending·0 cites
- 2149US2015182595A1Preparation Comprising Insulin, Nicotinamide and an Amino AcidNOVO NORDISK AS·Filed 2015·Application pending·0 cites
- 2246US2009054305A1Mixtures of Amylin and InsulinNOVO NORDISK AS·Filed 2007·Application pending·0 cites
- 2343US2005065066A1Stabilised insulin compositionsFiled 2004·Application pending·0 cites
- 2442US2009011976A1Stable Formulations Of PeptidesNOVO NORDISK AS·Filed 2005·Application pending·0 cites
- 2542US2008280814A1Pharmaceutical Compositions Containing Insulin and Insulinotropic PeptideNOVO NORDISK AS·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →